HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Heme oxygenase-1 is upregulated in the kidney of angiotensin II-induced hypertensive rats : possible role in renoprotection.

Abstract
In this study, we investigated the regulation and physiological role of heme oxygenase-1 (HO-1) in the kidney of rats with hypertension. Rats were continuously administered either angiotensin II (Ang II) or norepinephrine with an osmotic minipump for up to 7 days. Ang II infusion decreased the glomerular filtration rate (GFR) as determined through creatinine clearance (3.2+/-0.2 versus 1.2+/-0.2 mL/min with Ang II infusion, P<0.01) and increased proteinuria (9. 7+/-1.3 versus 28.1+/-7.2 mg/d with Ang II infusion, P<0.01). In contrast, norepinephrine did not alter these laboratory values. Ang II infusion significantly increased HO-1 expression in mRNA (442+/-98% of control at day 5, P<0.01) and protein levels (314+/-49% of control at day 5, P<0.01). Immunohistochemistry showed that in the kidney of normotensive rats, HO-1 was expressed mainly in the basal side in the renal tubules. After Ang II infusion, HO-1 staining was more extensively dispersed in the tubular epithelial cells. The intraperitoneal administration of zinc protoporphyrin, an HO inhibitor, to Ang II-infused rats further decreased GFR (0.8+/-0. 1 mL/min) and increased proteinuria (52.5+/-13.0 mg/d). In contrast, the administration of hemin, an HO inducer, ameliorated the Ang II-induced decrease in GFR (2.4+/-0.2 mL/min) and increase in proteinuria (9.3+/-4.5 mg/d). These data suggest that HO-1 upregulation in the kidney of Ang II-induced hypertensive rats may exert a renoprotective effect against Ang II-induced renal injury.
AuthorsT Aizawa, N Ishizaka, J i Taguchi, R Nagai, I Mori, S S Tang, J R Ingelfinger, M Ohno
JournalHypertension (Dallas, Tex. : 1979) (Hypertension) Vol. 35 Issue 3 Pg. 800-6 (Mar 2000) ISSN: 1524-4563 [Electronic] United States
PMID10720598 (Publication Type: Journal Article)
Chemical References
  • Antihypertensive Agents
  • Enzyme Inhibitors
  • Protoporphyrins
  • RNA, Messenger
  • Vasoconstrictor Agents
  • Vasodilator Agents
  • Angiotensin II
  • zinc protoporphyrin
  • Hydralazine
  • Hemin
  • Heme Oxygenase (Decyclizing)
  • Heme Oxygenase-1
  • Losartan
  • Norepinephrine
Topics
  • Angiotensin II (pharmacology)
  • Animals
  • Antihypertensive Agents (pharmacology)
  • Blood Pressure (drug effects)
  • Cell Line, Transformed
  • Disease Models, Animal
  • Enzyme Inhibitors (pharmacology)
  • Gene Expression Regulation, Enzymologic (drug effects)
  • Glomerular Filtration Rate (drug effects)
  • Heart Rate (drug effects)
  • Heme Oxygenase (Decyclizing) (analysis, genetics, metabolism)
  • Heme Oxygenase-1
  • Hemin (pharmacology)
  • Hydralazine (pharmacology)
  • Hypertension (chemically induced, metabolism)
  • Immunohistochemistry
  • Kidney Tubules, Proximal (cytology, enzymology)
  • Losartan (pharmacology)
  • Norepinephrine (pharmacology)
  • Oxidative Stress (drug effects)
  • Proteinuria (chemically induced, metabolism)
  • Protoporphyrins (pharmacology)
  • RNA, Messenger (analysis)
  • Rats
  • Rats, Sprague-Dawley
  • Vasoconstrictor Agents (pharmacology)
  • Vasodilator Agents (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: